Regulus Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2016
Period Ending	Sep '18 Sep 30, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Net Income	-0.66	-0.09	0.04
Other Amortization	0.03	0.01	-
Stock-Based Compensation	0.39	0.03	-
Other Operating Activities	-	0.03	-
Change in Other Net Operating Assets	0.01	0	-
Operating Cash Flow	-0.23	-0.03	0.04
Cash Acquisitions	-	0.01	-
Investing Cash Flow	-0.01	0.01	-
Short-Term Debt Issued	-	0.03	-
Total Debt Issued	0.16	0.03	-
Short-Term Debt Repaid	-	-0	-
Total Debt Repaid	-0	-0	-
Net Debt Issued (Repaid)	0.16	0.02	-
Issuance of Common Stock	0.09	-	0.01
Financing Cash Flow	0.24	0.02	0.01
Net Cash Flow	0	-0	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.